DOI QR코드

DOI QR Code

Biruloquinone, an Acetylcholinesterase Inhibitor Produced by Lichen-Forming Fungus Cladonia macilenta

  • Luo, Heng (Department of Biology and Chemical Engineering, Jiangsu University of Science and Technology) ;
  • Li, Changtian (College of Chinese Medicine Materials, Jilin Agricultural University) ;
  • Kim, Jin Cheol (Eco-friendly New Materials Research Group, Korea Research Institute of Chemical Technology) ;
  • Liu, Yanpeng (Department of Biology and Chemical Engineering, Jiangsu University of Science and Technology) ;
  • Jung, Jae Sung (Korean Lichen Research Institute, Sunchon National University) ;
  • Koh, Young Jin (Korean Lichen Research Institute, Sunchon National University) ;
  • Hur, Jae-Seoun (Korean Lichen Research Institute, Sunchon National University)
  • Received : 2012.07.13
  • Accepted : 2012.09.10
  • Published : 2013.02.28

Abstract

At present, acetylcholinesterase (AChE) inhibitors are the first group of drugs to treat mild to moderate Alzheimer's disease (AD). Although beneficial in improving cognitive and behavioral symptoms, the effectiveness of AChE inhibitors has been questioned since they do not delay or prevent neurodegeneration in AD patients. Therefore, in the present study, in order to develop new and effective anti-AD agents from lichen products, both the AChE inhibitory and the neuroprotective effects were evaluated. The AChE inhibitory assay was performed based on Ellman's reaction, and the neuroprotective effect was evaluated by using the MTT method on injured PC12 cells. One AChE inhibitor ($IC_{50}$ = 27.1 ${\mu}g/ml$) was isolated by means of bioactivity-guided isolation from the extract of lichen-forming fungus Cladonia macilenta, which showed the most potent AChE inhibitory activity in previous screening experiment. It was then identified as biruloquinone by MS, and $^1H$- and $^{13}C$-NMR analyses. The inhibitory kinetic assay suggested that biruloquinone is a mixed-II inhibitor on AChE. Meanwhile, biruloquinone improved the viability of the $H_2O_2$- and ${\beta}$-amyloid-injured PC12 cells at 1 to 25 ${\mu}g/ml$. The protective effects are proposed to be related to the potent antioxidant activities of biruloquinone. These results imply that biruloquinone has the potential to be developed as a multifunctional anti- AD agent.

Keywords

References

  1. Armone, A., G. Nasini, and O. V. de Para. 1991. A reinvestigation of the structure of biruloquinone, a 9,10-phenanthrenequinone isolated from Mycosphaerella rubella. Phytochemistry 31: 2729-2731.
  2. Barkats, M., S. Millecamps, P. Abrioux, M. C. Geoffroy, and J. Mallet. 2000. Overexpression of glutathione peroxidase increases the resistance of neuronal cells to A$\beta$-mediated neurotoxicity. J. Neurochem. 75: 1438-1446.
  3. Boldogh, I., M. L. Kruzel, and T. M. Colostrinin. 2008. An oxidative stress modulator for prevention and treatment of agerelated disorders. J. Alzheimers Dis. 13: 303-321. https://doi.org/10.3233/JAD-2008-13308
  4. Ellman, G. L. and K. D. Courtney. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-90. https://doi.org/10.1016/0006-2952(61)90145-9
  5. Keston, A. S. and R. Brandt. 1965. The fluorometric analysis of ultramicro quantities of hydrogen peroxide. Anal. Biochem. 11: 1-5. https://doi.org/10.1016/0003-2697(65)90034-5
  6. Krivoshchekova, O. E., L. S. Stepanenko, N. P. Mishchenko, V. A. Denisenko, and O. B. Maksimov. 1983. A study of aromatic metabolites of lichens of the family Parmeliaceae. II. Pigments. Chem. Nat. Comp. 19: 270-274. https://doi.org/10.1007/BF00579756
  7. Lenta, B. N., K. P. Devkota, S. Ngouela, F. F. Boyom, Q. Naz, M. I. Choudhary, E. Tsamo, P. J. Rosenthal, and N. Sewald. 2008. Anti-plasmodial and cholinesterase inhibiting activities of some constituents of Psorospermum glaberrimum. Chem. Pharm. Bull. 56: 222-226. https://doi.org/10.1248/cpb.56.222
  8. Lovell, M. A. and W. R. Markesbery. 2007. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J. Neurosci. Res. 85: 3036-3040. https://doi.org/10.1002/jnr.21346
  9. Moon, J. H., S. Y. Kim, H. G. Lee, S. U. Kim, and Y. B. Lee. 2008. Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar $\beta$amyloid peptide (1-42)-stimulated microglia. Exp. Mol. Med. 40: 11-18. https://doi.org/10.3858/emm.2008.40.1.11
  10. Mukherjee, P. K., V. Kumar, M. Mal, and P. J. Houghton. 2007. Acetylcholinesterase inhibitors from plants. Phytomedicine 14: 289-300. https://doi.org/10.1016/j.phymed.2007.02.002
  11. Ogura, H., T. Kosasa, Y. Kuriya, and Y. Yamanishi. 2000. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find. Exp. Clin. Pharmacol. 22: 609-613. https://doi.org/10.1358/mf.2000.22.8.701373
  12. Oksanen, I. 2006. Ecological and biotechnological aspects of lichens. Appl. Microbiol. Biotechnol. 73: 723-734. https://doi.org/10.1007/s00253-006-0611-3
  13. Roberson, E. and L. Mucke. 2006. 100 years and counting: Prospects for defeating Alzheimer's disease. Science 314: 781-784 https://doi.org/10.1126/science.1132813
  14. Sayre, L. M., G. Perry, and M. A. Smith. 2008. Oxidative stress and neurotoxicity. Chem. Res. Toxicol. 21: 172-188. https://doi.org/10.1021/tx700210j
  15. Shi, D. H., J. H. Wu, H. M. Ge, and R. X. Tan. 2009. Protective effect of hopeahainol A, a novel acetylcholinesterase inhibitor, on hydrogen peroxide-induced injury in PC12 cells. Environ. Toxicol. Pharmacol. 28: 30-36. https://doi.org/10.1016/j.etap.2009.01.009
  16. Small, D. H. 2005. Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: Do we need new inhibitors? Expert Opin. Emerg. Drugs 10: 817-825. https://doi.org/10.1517/14728214.10.4.817
  17. Stocker-Worgotter, E. 2008. Metabolic diversity of lichenforming ascomycetous fungi: Culturing, polyketide and shikimate metabolite production, and PKS genes. Nat. Prod. Rep. 25: 188-200. https://doi.org/10.1039/b606983p
  18. Sultana, R., S. Newman, H. Mohmmad-Abdul, J. N. Keller, and D. A. Butterfield. 2004. Protective effect of the xanthate, D609, on Alzheimer's amyloid $\beta$-peptide (1-42)-induced oxidative stress in primary neuronal cells. Free Radic. Res. 38: 449-458. https://doi.org/10.1080/1071576042000206478
  19. Terry, A. V. and J. J. Buccafusco. 2003. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 306: 821-827. https://doi.org/10.1124/jpet.102.041616
  20. Wimo, A., B. Winblad, and L. Jönsson. 2007. An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement. 3: 81-91. https://doi.org/10.1016/j.jalz.2007.02.001
  21. Yamamoto, Y. 2002. Discharge and germination of lichen ascospores in the laboratory. Lichenology 1: 11-22. (in Japanese)

Cited by

  1. Recent literature on lichens-231 vol.116, pp.4, 2013, https://doi.org/10.1639/0007-2745-116.4.399
  2. Draft Genome Sequence of Cladonia macilenta KoLRI003786, a Lichen-Forming Fungus Producing Biruloquinone vol.1, pp.5, 2013, https://doi.org/10.1128/genomea.00695-13
  3. A marine sponge associated strain of Bacillus subtilis and other marine bacteria can produce anticholinesterase compounds vol.13, pp.None, 2013, https://doi.org/10.1186/1475-2859-13-24
  4. Antioxidant Activity and Mechanisms of Action of Natural Compounds Isolated from Lichens: A Systematic Review vol.19, pp.9, 2013, https://doi.org/10.3390/molecules190914496
  5. Ramalina capitata (Ach.) Nyl. acetone extract: HPLC analysis, genotoxicity, cholinesterase, antioxidant and antibacterial activity vol.16, pp.None, 2017, https://doi.org/10.17179/excli2017-301
  6. Copper(0)/Selectfluor System-Promoted Oxidative Carbon–Carbon Bond Cleavage/Annulation of o-Aryl Chalcones: An Unexpected Synthesis of 9,10-Phenanthraquinone Derivatives vol.82, pp.1, 2017, https://doi.org/10.1021/acs.joc.6b02212
  7. Research Advances and Detection Methodologies for Microbe-Derived Acetylcholinesterase Inhibitors: A Systemic Review vol.22, pp.1, 2017, https://doi.org/10.3390/molecules22010176
  8. Secondary metabolism in the lichen symbiosis vol.47, pp.5, 2013, https://doi.org/10.1039/c7cs00431a
  9. Introduction of marine‐derived Streptomyces sp. UTMC 1334 as a source of pyrrole derivatives with anti‐acetylcholinesterase activity vol.125, pp.5, 2013, https://doi.org/10.1111/jam.14043
  10. Suzuki cross coupling followed by cross dehydrogenative coupling: An efficient one pot synthesis of Phenanthrenequinones and analogues vol.61, pp.13, 2013, https://doi.org/10.1016/j.tetlet.2020.151701
  11. Establishment of Agrobacterium tumefaciens-Mediated Transformation of Cladonia macilenta, a Model Lichen-Forming Fungus vol.7, pp.4, 2013, https://doi.org/10.3390/jof7040252
  12. Transcriptome Analysis Identifies a Gene Cluster for the Biosynthesis of Biruloquinone, a Rare Phenanthraquinone, in a Lichen-Forming Fungus Cladonia macilenta vol.7, pp.5, 2013, https://doi.org/10.3390/jof7050398
  13. Linking a Gene Cluster to Atranorin, a Major Cortical Substance of Lichens, through Genetic Dereplication and Heterologous Expression vol.12, pp.3, 2013, https://doi.org/10.1128/mbio.01111-21
  14. Potent and Selective Inhibitors of Human Monoamine Oxidase A from an Endogenous Lichen Fungus Diaporthe mahothocarpus vol.7, pp.10, 2013, https://doi.org/10.3390/jof7100876